Neogen Corporation (NEOG)
NASDAQ: NEOG · IEX Real-Time Price · USD
12.45
+0.20 (1.63%)
May 2, 2024, 3:59 PM EDT - Market closed
Neogen Revenue
Neogen had revenue of $929.24M in the twelve months ending February 29, 2024, with 28.93% growth year-over-year. Revenue in the quarter ending February 29, 2024 was $228.81M with 4.84% year-over-year growth. In the fiscal year ending May 31, 2023, Neogen had annual revenue of $822.45M with 56.01% growth.
Revenue (ttm)
$929.24M
Revenue Growth
+28.93%
P/S Ratio
2.86
Revenue / Employee
$351,984
Employees
2,640
Market Cap
2.70B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2023 | 822.45M | 295.29M | 56.01% |
May 31, 2022 | 527.16M | 58.70M | 12.53% |
May 31, 2021 | 468.46M | 50.29M | 12.03% |
May 31, 2020 | 418.17M | 3.98M | 0.96% |
May 31, 2019 | 414.19M | 16.26M | 4.09% |
May 31, 2018 | 397.93M | 39.65M | 11.07% |
May 31, 2017 | 358.28M | 37.00M | 11.52% |
May 31, 2016 | 321.28M | 38.20M | 13.50% |
May 31, 2015 | 283.07M | 35.67M | 14.42% |
May 31, 2014 | 247.41M | 39.88M | 19.22% |
May 31, 2013 | 207.53M | 23.48M | 12.76% |
May 31, 2012 | 184.05M | 11.36M | 6.58% |
May 31, 2011 | 172.68M | 32.17M | 22.90% |
May 31, 2010 | 140.51M | 21.79M | 18.35% |
May 31, 2009 | 118.72M | 16.30M | 15.92% |
May 31, 2008 | 102.42M | 16.28M | 18.90% |
May 31, 2007 | 86.14M | 13.71M | 18.92% |
May 31, 2006 | 72.43M | 9.68M | 15.42% |
May 31, 2005 | 62.76M | 7.26M | 13.08% |
May 31, 2004 | 55.50M | 7.81M | 16.38% |
May 31, 2003 | 47.69M | 5.62M | 13.36% |
May 31, 2002 | 42.07M | 7.17M | 20.55% |
May 31, 2001 | 34.90M | 11.38M | 48.41% |
May 31, 2000 | 23.51M | 1.33M | 6.01% |
May 31, 1999 | 22.18M | 3.69M | 19.96% |
May 31, 1998 | 18.49M | 3.23M | 21.16% |
May 31, 1997 | 15.26M | 2.77M | 22.17% |
May 31, 1996 | 12.49M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
QuidelOrtho | 3.00B |
Premier | 1.32B |
PTC Therapeutics | 927.56M |
MorphoSys AG | 264.75M |
Arcellx | 110.32M |
Rhythm Pharmaceuticals | 77.43M |
Merus | 43.95M |
Celldex Therapeutics | 6.88M |
NEOG News
- 1 day ago - Neogen® Petrifilm® Celebrates 40 Years! - PRNewsWire
- 2 days ago - Neogen® Launches New Molecular Method for Detection of Two Salmonella Serotypes - PRNewsWire
- 14 days ago - Neogen® Forms Genomics Relationship with Performance Food Group - PRNewsWire
- 21 days ago - Neogen® Farm Fluid MAX Disinfectant Launches Across Great Britain Livestock & Poultry Markets - PRNewsWire
- 23 days ago - Neogen Stock Is Tumbling. Revenue Guidance Was Cut. - Barrons
- 23 days ago - Neogen Announces Third-Quarter 2024 Results - PRNewsWire
- 6 weeks ago - Neogen Announces Third-Quarter Earnings Release Date - PRNewsWire
- 3 months ago - Neogen® Announces James Walter as Vice President, Global Operations - PRNewsWire